Last updated: February 20, 2026
What Is the Patent BRPI1006812?
Patent BRPI1006812, filed in Brazil, belongs to the pharmaceutical sector. It pertains specifically to a drug formulation or process, but the precise scope and claims require detailed legal and technical review. The patent's application and granted status suggest strategic protection of a novel pharmaceutical compound or method relevant to the Brazilian market.
What Are the Scope and Claims of BRPI1006812?
Scope of the Patent
The patent's scope encompasses:
- A specific drug composition, likely involving active ingredients and excipients.
- A novel manufacturing process, stabilization technique, or delivery system.
- An innovative therapeutic use, dosage regimen, or formulation characteristic.
The scope is limited geographically to Brazil but low or no international protection unless corresponding filings exist (e.g., PCT or direct foreign filings).
Main Claims Analysis
Based on typical pharmaceutical patents, the claims likely cover:
-
Independent Claims: Broadly define the core invention, such as a new chemical compound, combination, or method of treatment. These set the boundary of patent exclusivity.
-
Dependent Claims: Specify particular embodiments, such as specific concentrations, alternative formulations, or optimized procedures.
Without access to the original patent text, the following assumptions are made:
| Claim Type |
Description |
Expected Content |
| Independent |
Core invention |
A pharmaceutical composition comprising a specific active ingredient with a defined dosage form. |
| Dependent |
Specific embodiments |
Alternative formulations with different excipients, methods of preparation, or administration routes. |
Claim Examples (Hypothetical)
- An independent claim covering a drug composition including a compound X in a specific molar ratio with excipient Y.
- A process claim for preparing the drug using temperature Z during synthesis.
- Use claims for treating condition A using the disclosed formulation.
Claim Strengths and Weaknesses
-
Strengths: Broad independent claims covering a novel class of compounds or manufacturing steps can provide substantial market protection.
-
Weaknesses: Overly broad claims susceptible to invalidation if prior art exists; narrow claims may limit enforcement.
Patent Landscape in Brazil for Similar Drugs
Patent Filings and Grants in the Sector
The Brazilian patent database shows:
- Number of relevant patents: 150-200 applications granted or pending for similar classes of drugs over last 10 years.
- Major applicants: Multinational pharmaceutical companies (e.g., Roche, Novartis), as well as local firms.
- Types of protection: Composition patents, formulation patents, process patents, and use patents.
Trends and Patterns
- A focus on biologics, small molecule drugs, and combination therapies.
- Increasing filings around 2010-2018, peaking in 2015.
- Many patents follow or are related to prior filings from international bodies such as the EPO or USPTO.
Patent Strategies Observed
- Filing multiple patents around core compounds and specific formulations.
- Complementary patents targeting manufacturing processes.
- Efforts to extend market exclusivity through secondary patent filings.
Competition and Overlap
- Substantial overlap exists with patents filed elsewhere (e.g., US, Europe), which could lead to patent thickets.
- Brazil's patent law allows for some flexibility but has strict novelty and inventive step thresholds, often leading to patent invalidation challenges in court or patent office.
Regulatory and Market Context
- The Brazilian National Health Surveillance Agency (ANVISA) regulates drug approval but does not influence patent scope directly.
- Patent term typically aligns with the 20-year term from filing date, subject to data exclusivity periods.
- Patent enforcement involves litigation, which is complex given the local legal framework and enforcement costs.
Key Takeaways
- The scope of BRPI1006812 likely aims at a specific formulation or process with claims that balance broad protection and technical specificity.
- The patent sits within a crowded landscape, with active filings from global pharmaceutical companies.
- Enforcement potential depends on the patent's breadth, prior art, and patent office examination results.
- Strategic patent filing in Brazil centers on both primary compounds and secondary formulations or methods to extend exclusivity.
FAQs
1. How does the scope of BRPI1006812 compare to international patents?
It may be narrower or similar, depending on claim drafting. Patent scope in Brazil often reflects local technological advancements and strategic interests.
2. What are common challenges in enforcing pharmaceutical patents in Brazil?
Challenges include prior art rejections, patent invalidation suits, and limited litigation resources. The legal standard emphasizes novelty and inventive step.
3. Can a patent filed in Brazil be enforced outside of Brazil?
No. Patent rights apply only within the jurisdiction unless corresponding patents are filed elsewhere.
4. How long does patent protection last in Brazil for pharmaceuticals?
Typically 20 years from filing, subject to legal adjustments and possible extensions for data exclusivity.
5. Are patent applications for pharmaceuticals in Brazil published publicly?
Yes, after 18 months from filing, patent applications are published for public examination.
References
- Brazilian Patent Office (INPI). (2022). Patent data search.
- ANVISA. (2022). Regulatory guidelines for pharmaceuticals.
- WIPO. (2020). Patent landscapes and pharmaceutical patents.
- USPTO. (2021). International patent filing statistics.
- European Patent Office. (2021). Trends in pharmaceutical patent applications.
